Metagenomic analysis of cerebrospinal fluid from patients with multiple sclerosis

Advances in Experimental Medicine and Biology

Volumn 935, Issue , 2016, Pages 89-98

  Perlejewski, Karol ^a   Bukowska Ośko, Iwona ^a   Nakamura, Shota ^b   Motooka, Daisuke ^b   Stokowy, Tomasz ^c   Płoski, Rafał ^a   Rydzanicz, Małgorzata ^a   Zakrzewska Pniewska, Beata ^a   Podlecka Piętowska, Aleksandra ^a   Nojszewska, Monika ^a   Gogol, Anna ^a   Caraballo Cortés, Kamila ^a   Demkow, Urszula ^a   Stępień, Adam ^d   Laskus, Tomasz ^a   Radkowski, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF BERGEN   (Norway)

^d MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Cerebrospinal fluid; Idiopathic inflammatory demyelinating disorder; Metagenomics; Multiple sclerosis; Next generation sequencing

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; BACTERIUM; BACTERIUM CONTAMINATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; FUNGUS; GENE AMPLIFICATION; HUMAN; IDIOPATHIC INFLAMMATORY DEMYELINATING DISORDER; MALE; METAGENOMICS; MICROBIAL IDENTIFICATION; MICROORGANISM DETECTION; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEXT GENERATION SEQUENCING; NON INFLAMMATORY NEUROLOGICAL DISEASE; OPTIC NEURITIS; PARASITE; PRIORITY JOURNAL; PROTOZOON; SINGLE PRIMER ISOTHERMAL AMPLIFICATION; VARICELLA ZOSTER VIRUS; CEREBROSPINAL FLUID; GENETICS; HERPES ZOSTER; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; PROCEDURES; VIROLOGY; YOUNG ADULT;

ADULT; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; METAGENOMICS; MIDDLE AGED; MULTIPLE SCLEROSIS; RNA, VIRAL; YOUNG ADULT;

EID: 84982261389     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2016_25     Document Type: Chapter

References (37)

1. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 61(6):504-513.
2. Benito-Leon J, Pisa D, Alonso R, Calleja P, Diaz- Sanchez M, Carrasco L (2010) Association between multiple sclerosis and Candida species: evidence from a case-control study. Eur J Clin Microbiol Infect Dis 29(9):1139-1145.
3. Borkosky SS, Whitley C, Kopp-Schneider A, zur Hausen H, de Villiers EM (2012) Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. PLoS ONE 7(2): e32160. doi:10.1371/journal.pone.0032160.
4. Brahic M (2010) Multiple sclerosis and viruses. Ann Neurol 68(1):6-8.
5. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM (2015) Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med 63(5):729-734.
6. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15:532-537.
7. FASTX-Toolkit (2016) FASTQ/A short-reads pre-processing tools. http://hannonlab.cshl.edu/fastx_ toolkit/index.html. Accessed on 11. April 2016.
8. Goto N, Prins P, Nakao M, Bonnal R, Aerts J, Katayama T (2010) BioRuby: bioinformatics software for the Ruby programming language. Bioinformatics 26 (20):2617-2619.
9. Hansen JJ (2015) Immune responses to intestinal microbes in inflammatory bowel diseases. Curr Allergy Asthma Rep 15(10):562. doi:10.1007/s11882-015-0562-9.
10. Hughes LE, Bonell S, Natt RS, Wilson C, Tiwana H, Ebringer A, Cunningham P, Chamoun V, Thompson EJ, Croker J, Vowles J (2001) Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-acinetobacter-neurofilament antibody index. Clin Diagn Lab Immunol 8(6):1181-1188.
11. Joscelyn J, Kasper LH (2014) Digesting the emerging role for the gut microbiome in central nervous system demyelination. Mult Scler 20(12):1553-1559.
12. Kakalacheva K, Munz C, Lunemann JD (2011) Viral triggers of multiple sclerosis. Biochim Biophys Acta 1812(2):132-140.
13. Krametter D, Niederwieser G, Berghold A, Birnbaum G, Strasser-Fuchs S, Hartung HP, Archelos JJ (2001) Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 7(1):13-18.
14. Laurence M, Hatzis C, Brash DE (2014) Common contaminants in next-generation sequencing that hinder discovery of low-abundance microbes. PLoS ONE 9(5):e97876. doi:10.1371/journal.pone.0097876.
15. Lunter G, Goodson M (2011) Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res 21(6):936-939.
16. Mancuso R, Delbue S, Borghi E, Pagani E, Calvo MG, Caputo D, Granieri E, Ferrante P (2007) Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 79(2):192-199.
17. Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3(12):709-718.
18. Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. 17(1); doi: 10.14806/ej.17.1.200.
19. Miller RR, Montoya V, Gardy JL, Patrick DM, Tang P (2013) Metagenomics for pathogen detection in public health. Genome Med 5(9):81. doi:10.1186/gm485.
20. Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, Morita H, Hattori M, Yamamura T (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS ONE 10(9): e0137429. doi:10.1371/journal.pone.0137429.
21. Norrby E, Link H, Olsson JE (1974) Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. Arch Neurol 30(4):285-292.
22. O’Gorman C, Lucas R, Taylor B (2012) Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 13 (9):11718-11752.
23. Ordonez G, Pineda B, Garcia-Navarrete R, Sotelo J (2004) Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol 61(4):529-532.
24. Padmanabhan R, Mishra AK, Raoult D, Fournier PE (2013) Genomics and metagenomics in medical microbiology. J Microbiol Methods 95(3):415-424.
25. Pender MP, Burrows SR (2014) Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunol 3(10):e27. doi:10.1038/cti.2014.25.
26. Perlejewski K, Popiel M, Laskus T, Nakamura S, Motooka D, Stokowy T, Lipowski D, Pollak A, Lechowicz U, Caraballo Corteé K, Stępień A, Radkowski M, Bukowska-Osko I (2015) Nextgeneration sequencing (NGS) in the identification of encephalitis-causing viruses: unexpected detection of human herpesvirus 1 while searching for RNA pathogens. J Virol Methods 226:1-6.
27. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292-302.
28. Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313-323.
29. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW (2014) Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 12:87. doi:10.1186/s12915-014-0087-z
30. Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW(1996) Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol 53(2):125-133.
31. Sleator RD, Shortall C, Hill C (2008) Metagenomics. Lett Appl Microbiol 47(5):361-366.
32. Sotelo J, Martinez-Palomo A, Ordonez G, Pineda B (2008) Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis. Ann Neurol 63 (3):303-311.
33. Sotelo J, Ordonez G, Pineda B, Flores J (2014) The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg 119:44-48.
34. Swanborg RH, Whittum-Hudson JA, Hudson AP (2003) Infectious agents and multiple sclerosis-are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 136(1-2):1-8.
35. Weiss S, Amir A, Hyde ER, Metcalf JL, Song SJ, Knight R (2014) Tracking down the sources of experimental contamination in microbiome studies. Genome Biol 15(12):564. doi:10.1186/s13059-014-0564-2.
36. Zawada M (2012) Potential pathogens in multiple sclerosis (MS). Postepy Hig Med Dosw (Online) 66:758-770.
37. Zivadinov R, Nasuelli D, Tommasi MA, Serafin M, Bratina A, Ukmar M, Pirko I, Johnson AJ, Furlan C, Pozzi-Mucelli RS, Monti-Bragadin L, Grop A, Zambon M, Antonello RM, Cazzato G, Zorzon M (2006) Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 28(3):262-269